HIT topics on FDA's guidance priority list

Beth Walsh | | Health Exec | Artificial Intelligence

Several health IT issues are on the FDA's list of guidance priorities for 2015.

The agency broke its priorities out into three lists. The A list covers those guidance documents the agency intends to publish; the B list includes those the agency intends to publish if resources permit; and another list is of previously released guidance documents for which the agency is seeking "retrospective review."

The A list includes both final and draft guidance on medical device decision support software and unique device identifiers. The B list includes medical device interoperability and patient access to health data.

Access the guidance document list.

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Related Content

5 ways to let AI raise patient satisfaction, elevate provider performance
Medtronic using AI to identify more TAVR patients in need
When life sciences met artificial intelligence
AdvaMed itemizes AI imperatives for ‘the entire healthcare ecosystem’
6 things high-achieving orgs do to wring real value from AI
A modest proposal to rally AI regulators around a simple game plan

Around the web

Cardiovascular Business
Payment cuts and beyond: Key takeaways for cardiologists from the 2025 Medicare Physician Fee Schedule

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

AI in Healthcare
A modest proposal to rally AI regulators around a simple game plan

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

Cardiovascular Business
FDA commissioner urges clinicians to join fight against medical misinformation

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."